Education
About Us
Working with TipRanks
Follow Us
NFL Biosciences SA (DE:82F)
:82F
Total Valuation
NFL Biosciences SA has a market cap or net worth of €14.51M. The enterprise value is €9.32M.
Market Cap€14.51M
Enterprise Value€9.32M
Share Statistics
NFL Biosciences SA has 12,672,242 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding12,672,242
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
NFL Biosciences SA’s return on equity (ROE) is -2.90 and return on invested capital (ROIC) is -283.95%.
Return on Equity (ROE)-2.90
Return on Assets (ROA)-1.02
Return on Invested Capital (ROIC)-283.95%
Return on Capital Employed (ROCE)-3.65
Revenue Per Employee0.00
Profits Per Employee-610.87K
Employee Count4
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of NFL Biosciences SA is -4.21. NFL Biosciences SA’s PEG ratio is -0.03.
PE Ratio-4.21
PS Ratio0.00
PB Ratio12.19
Price to Fair Value12.19
Price to FCF98.07
Price to Operating Cash Flow98.07
PEG Ratio-0.03
Income Statement
In the last 12 months, NFL Biosciences SA had revenue of 0.00 and earned -2.44M in profits. Earnings per share was -0.47.
Revenue0.00
Gross Profit-2.24M
Operating Income-3.08M
Pretax Income-2.86M
Net Income-2.44M
EBITDA-2.81M
Earnings Per Share (EPS)-0.47
Cash Flow
In the last 12 months, operating cash flow was 110.93K and capital expenditures 0.00, giving a free cash flow of 110.93K billion.
Operating Cash Flow110.93K
Free Cash Flow110.93K
Free Cash Flow per Share<0.01
Dividends & Yields
NFL Biosciences SA pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.15
52-Week Price Change-58.08%
50-Day Moving Average1.26
200-Day Moving Average1.62
Relative Strength Index (RSI)47.55
Average Volume (3m)50.00
Important Dates
NFL Biosciences SA upcoming earnings date is Oct 24, 2025, Before Open (Confirmed).
Last Earnings DateApr 11, 2025
Next Earnings DateOct 24, 2025
Ex-Dividend Date―
Financial Position
NFL Biosciences SA as a current ratio of 1.46, with Debt / Equity ratio of 9.86%
Current Ratio1.46
Quick Ratio1.46
Debt to Market Cap<0.01
Net Debt to EBITDA0.35
Interest Coverage Ratio-6.25K
Taxes
In the past 12 months, NFL Biosciences SA has paid -417.83K in taxes.
Income Tax-417.83K
Effective Tax Rate0.15
Enterprise Valuation
NFL Biosciences SA EV to EBITDA ratio is -3.32, with an EV/FCF ratio of 88.82.
EV to Sales0.00
EV to EBITDA-3.32
EV to Free Cash Flow88.82
EV to Operating Cash Flow88.82
Balance Sheet
NFL Biosciences SA has €3.56M in cash and marketable securities with €72.73K in debt, giving a net cash position of -€3.49M billion.
Cash & Marketable Securities€3.56M
Total Debt€72.73K
Net Cash-€3.49M
Net Cash Per Share-€0.28
Tangible Book Value Per Share€0.14
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for NFL Biosciences SA is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―